Literature DB >> 3385914

Pulmonary hypertension in progressive muscular dystrophy of the Duchenne type.

M Yotsukura1, M Miyagawa, T Tsuya, T Ishihara, K Ishikawa.   

Abstract

Right heart catheterization was performed in 8 patients with progressive muscular dystrophy of the Duchenne type (DMD) at the advanced stage. A mean pulmonary arterial pressure in excess of 20 mmHg was observed in all cases. Five of them showed severe pulmonary hypertension with a mean pressure above 40 mmHg. Since pulmonary hypertension was relieved by correction of hypoxemia, this represented a precapillary pulmonary hypertension caused by constriction of the pulmonary artery. Furthermore, elevation of the mean right atrial pressure above 5 mmHg was observed in 6 of the 8 cases, indicating the possible presence of right ventricular failure. Despite the presence of left ventricular dysfunction as assessed by echocardiogram, no manifestations of left ventricular failure, such as dyspnea and pulmonary rales, were noted in any of the patients. In conclusion, it can be said that even in the terminal stage of DMD, the left ventricular function may, in fact, still remain not markedly involved, and that respiratory failure, as well as right ventricular failure caused by precapillary pulmonary hypertension, will tend to occur frequently and may play a determinant role in prognosis of the advanced DMD patient.

Entities:  

Mesh:

Year:  1988        PMID: 3385914     DOI: 10.1253/jcj.52.321

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  6 in total

1.  Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.

Authors:  Isabel Cristina Chagas Barbin; Juliano Alves Pereira; Matheus Bersan Rovere; Drielen de Oliveira Moreira; Maria Julia Marques; Humberto Santo Neto
Journal:  J Anat       Date:  2016-01-29       Impact factor: 2.610

2.  The possible role of chromosome X variability in hypertensive familiarity.

Authors:  M Ciccarelli; R Finelli; N Rivera; G Santulli; R Izzo; N De Luca; F Rozza; M Ceccarelli; S Pagnotta; F Uliano; R Tremigliozzi; G Condorelli; V Trimarco; G Iaccarino
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

Review 3.  Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options.

Authors:  Antonella LoMauro; Maria Grazia D'Angelo; Andrea Aliverti
Journal:  Ther Clin Risk Manag       Date:  2015-09-28       Impact factor: 2.423

4.  Ventilatory chemosensory drive is blunted in the mdx mouse model of Duchenne Muscular Dystrophy (DMD).

Authors:  Matias Mosqueira; Santhosh M Baby; Sukhamay Lahiri; Tejvir S Khurana
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

5.  Contribution of TRPC Channels to Intracellular Ca2 + Dyshomeostasis in Smooth Muscle From mdx Mice.

Authors:  Jose R Lopez; Arkady Uryash; Gilles Faury; Eric Estève; Jose A Adams
Journal:  Front Physiol       Date:  2020-02-20       Impact factor: 4.566

6.  Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

Authors:  Corinne A Betts; Graham McClorey; Richard Healicon; Suzan M Hammond; Raquel Manzano; Sofia Muses; Vicky Ball; Caroline Godfrey; Thomas M Merritt; Tirsa van Westering; Liz O'Donovan; Kim E Wells; Michael J Gait; Dominic J Wells; Damian Tyler; Matthew J Wood
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.